Medical Properties Trust, Inc. (MPW)
NYSE: MPW · Real-Time Price · USD
3.730
-0.030 (-0.80%)
Dec 27, 2024, 4:00 PM EST - Market closed
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MPW stock have an average target of 4.92, with a low estimate of 4.00 and a high estimate of 6.50. The average target predicts an increase of 31.90% from the current stock price of 3.73.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MPW stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 7 | 7 | 7 | 6 |
Sell | 4 | 4 | 2 | 2 | 2 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 13 | 10 | 10 | 10 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $6 → $4 | Hold | Maintains | $6 → $4 | +7.24% | Dec 19, 2024 |
Mizuho | Mizuho | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +34.05% | Dec 5, 2024 |
Truist Securities | Truist Securities | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | +60.86% | Sep 13, 2024 |
Colliers Securities | Colliers Securities | Hold → Strong Buy Upgrades $6.5 | Hold → Strong Buy | Upgrades | $6.5 | +74.26% | Sep 13, 2024 |
Exane BNP Paribas | Exane BNP Paribas | Buy → Hold Downgrades $6 → $4 | Buy → Hold | Downgrades | $6 → $4 | +7.24% | Jul 2, 2024 |
Financial Forecast
Revenue This Year
1.00B
Revenue Next Year
940.44M
from 1.00B
Decreased by -6.33%
EPS This Year
-2.67
from -0.93
EPS Next Year
0.25
from -2.67
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 1.1B | 1.1B | 1.1B | |||
Avg | 1.0B | 940.4M | 996.9M | |||
Low | 919.4M | 799.1M | 894.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | 10.4% | 16.3% | |||
Avg | - | -6.3% | 6.0% | |||
Low | - | -20.4% | -4.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.83 | 0.58 | 0.32 |
Avg | -2.67 | 0.25 | 0.20 |
Low | -3.05 | -0.02 | 0.05 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | 25.8% |
Avg | - | - | -19.4% |
Low | - | - | -80.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.